Tier 3 Community Dermatology Service to three GM localities: Manchester, Trafford and Tameside

The NHS Greater Manchester Integrated Care Board is overseeing a procurement process for Tier 3 Community Dermatology Services intended for the Greater Manchester area, specifically in Manchester, Trafford, and Tameside. The contract was set to commence on 1st April 2025 and run through 30th September 2025, valued at £1,685,775. This procurement falls under a Provider Selection Regime (PSR) Direct Award Process, and the notice serves as an intention to award under this regime.

Although an active contract status is indicated, it originally involved a standstill period for representations, closing by midnight on 22nd August 2025. The procurement process is under the category of services, specifically targeting dermatology services, and the procurement stage involved awards without prior publication of a competition call, due to being outside the directive's scope. This procurement process offers significant opportunities for businesses specialising in healthcare services, particularly those with expertise in dermatological care.

The direct award method signifies limited competition, suggesting that businesses with innovative solutions, a commitment to quality, and a capacity for integration and collaboration may thrive in such scenarios. The key award criteria emphasise aspects like quality, innovation, service sustainability, and social value. As the awarded company, About Health Limited exemplifies the large-scale capabilities sought by the NHS Greater Manchester Integrated Care Board, indicating potential growth for similar scale suppliers interested in public healthcare projects and those looking to establish significant footprints within the health services sector.